| Lyka Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.41 | 0.73 | 1.64 | 5.77 | 12.15 |
| Long Term Debt-Equity Ratio | 0.26 | 0.60 | 1.02 | 4.20 | 11.23 |
| Current Ratio | 1.30 | 1.25 | 0.68 | 0.62 | 0.84 |
| Fixed Assets | 0.79 | 0.69 | 0.50 | 0.98 | 0.41 |
| Inventory | 12.23 | 12.90 | 10.66 | 26.34 | 12.44 |
| Debtors | 4.07 | 4.96 | 4.64 | 11.96 | 7.55 |
| Interest Cover Ratio | 5.99 | 0.81 | 0.48 | 4.02 | 0.28 |
| PBIDTM (%) | 15.02 | 15.18 | 23.64 | 58.14 | 24.41 |
| PBITM (%) | 10.23 | 3.63 | 6.86 | 48.77 | 11.48 |
| PBDTM (%) | 13.31 | 10.67 | 9.28 | 46.02 | -16.62 |
| CPM (%) | 10.90 | 9.42 | 9.05 | 33.64 | -10.30 |
| APATM (%) | 6.11 | -2.13 | -7.73 | 24.28 | -23.23 |
| ROCE (%) | 6.37 | 0.00 | 0.00 | 35.98 | 0.00 |
| RONW (%) | 4.99 | 0.00 | 0.00 | 58.27 | 0.00 |